Download PDF
Clin Colon Rectal Surg 2022; 35(01): 058-065
DOI: 10.1055/s-0041-1740039
Review Article

Staging Pouch Surgery in Ulcerative Colitis in the Biological Era

Anton Risto
1   Department of Surgery, Linköping University Hospital and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
,
Maie Abdalla
2   Department of Surgery, Vrinnevi Hospital, Norrköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
,
Pär Myrelid
1   Department of Surgery, Linköping University Hospital and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Restorative proctocolectomy, or ileal pouch anal anastomosis, is considered the standard treatment for intractable ulcerative colitis. When the pelvic pouch was first introduced in 1978, a two-stage procedure with proctocolectomy, construction of the pelvic pouch, and a diverting loop with subsequent closure were suggested. Over the decades that the pelvic pouch has been around, some principal technical issues have been addressed to improve the method. In more recent days the laparoscopic approach has been additionally introduced. During the same time-period the medical arsenal has developed far more with the increasing use of immune modulators and the introduction of biologicals. Staging of restorative proctocolectomy with a pelvic pouch refers to how many sessions, or stages, the procedure should be divided into. The main goal with restorative proctocolectomy is a safe operation with optimal short- and long-term function. In this paper we aim to review the present knowledge and views on staging of the pouch procedure in ulcerative colitis, especially with consideration to the treatment with biologicals.

Keywords

ulcerative colitis - biological therapy - immunomodulators - surgery


Publication History

Article published online:
17 January 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Øresland T, Bemelman WA, Sampietro GM. et al; European Crohn's and Colitis Organisation (ECCO). European evidence based consensus on surgery for ulcerative colitis. J Crohn's Colitis 2015; 9 (01) 4-25
    CrossrefPubMedGoogle Scholar
  • 2 Blumberg D, Beck DE. Surgery for ulcerative colitis. Gastroenterol Clin North Am 2002; 31 (01) 219-235
    CrossrefPubMedGoogle Scholar
  • 3 Braveman JM, Schoetz Jr DJ, Marcello PW. et al. The fate of the ileal pouch in patients developing Crohn's disease. Dis Colon Rectum 2004; 47 (10) 1613-1619
    CrossrefPubMedGoogle Scholar
  • 4 Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease. Lancet 1996; 347 (9005): 854-857
    CrossrefPubMedGoogle Scholar
  • 5 Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis. BMJ 1978; 2 (6130): 85-88
    CrossrefPubMedGoogle Scholar
  • 6 Lovegrove RE, Constantinides VA, Heriot AG. et al. A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy: a meta-analysis of 4183 patients. Ann Surg 2006; 244 (01) 18-26
    CrossrefPubMedGoogle Scholar
  • 7 Chandrasinghe P, Carvello M, Wasmann K. et al. Transanal ileal pouch-anal anastomosis for ulcerative colitis has comparable long-term functional outcomes to transabdominal approach: a multicentre comparative study. J Crohn's Colitis 2020; 14 (06) 726-733
    CrossrefPubMedGoogle Scholar
  • 8 Worley G, Nordenvall C, Askari A. et al. Restorative surgery after colectomy for ulcerative colitis in England and Sweden: observations from a comparison of nationwide cohorts. Colorectal Dis 2018; 20 (09) 804-812
    CrossrefPubMedGoogle Scholar
  • 9 Axelrad JE, Roy A, Lawlor G, Korelitz B, Lichtiger S. Thiopurines and inflammatory bowel disease: current evidence and a historical perspective. World J Gastroenterol 2016; 22 (46) 10103-10117
    CrossrefPubMedGoogle Scholar
  • 10 Järnerot G, Hertervig E, Friis-Liby I. et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128 (07) 1805-1811
    CrossrefPubMedGoogle Scholar
  • 11 Singh S, Fumery M, Sandborn WJ, Murad MH. Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis. Aliment Pharmacol Ther 2018; 47 (02) 162-175
    CrossrefPubMedGoogle Scholar
  • 12 de Zeeuw S, Ahmed Ali U, Donders RA, Hueting WE, Keus F, van Laarhoven CJ. Update of complications and functional outcome of the ileo-pouch anal anastomosis: overview of evidence and meta-analysis of 96 observational studies. Int J Colorectal Dis 2012; 27 (07) 843-853
    CrossrefPubMedGoogle Scholar
  • 13 Forbes SS, O'Connor BI, Victor JC, Cohen Z, McLeod RS. Sepsis is a major predictor of failure after ileal pouch-anal anastomosis. Dis Colon Rectum 2009; 52 (12) 1975-1981
    CrossrefPubMedGoogle Scholar
  • 14 Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003; 238 (02) 229-234
    CrossrefPubMedGoogle Scholar
  • 15 Nordenvall C, Ekbom A, Bottai M, Smedby KE, Nilsson PJ. Mortality after total colectomy in 3084 patients with inflammatory bowel disease: a population-based cohort study. Aliment Pharmacol Ther 2014; 40 (03) 280-287
    CrossrefPubMedGoogle Scholar
  • 16 Tøttrup A, Erichsen R, Sværke C, Laurberg S, Srensen HT. Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study. BMJ Open 2012; 2 (02) e000823
    CrossrefPubMedGoogle Scholar
  • 17 Justiniano CF, Aquina CT, Becerra AZ. et al. Postoperative mortality after nonelective surgery for inflammatory bowel disease patients in the era of biologics. Ann Surg 2019; 269 (04) 686-691
    CrossrefPubMedGoogle Scholar
  • 18 Gu J, Stocchi L, Remzi F, Kiran RP. Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis. Colorectal Dis 2013; 15 (09) 1123-1129
    CrossrefPubMedGoogle Scholar
  • 19 Randall J, Singh B, Warren BF, Travis SP, Mortensen NJ, George BD. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg 2010; 97 (03) 404-409
    CrossrefPubMedGoogle Scholar
  • 20 Roberts SE, Williams JG, Yeates D, Goldacre MJ. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 2007; 335 (7628): 1033
    CrossrefPubMedGoogle Scholar
  • 21 Wong KS, Remzi FH, Gorgun E. et al. Loop ileostomy closure after restorative proctocolectomy: outcome in 1,504 patients. Dis Colon Rectum 2005; 48 (02) 243-250
    CrossrefPubMedGoogle Scholar
  • 22 Lavryk OA, Stocchi L, Hull TL. et al. Impact of preoperative duration of ulcerative colitis on long-term outcomes of restorative proctocolectomy. Int J Colorectal Dis 2020; 35 (01) 41-49
    CrossrefPubMedGoogle Scholar
  • 23 Weston-Petrides GK, Lovegrove RE, Tilney HS. et al. Comparison of outcomes after restorative proctocolectomy with or without defunctioning ileostomy. Arch Surg 2008; 143 (04) 406-412
    Google Scholar
  • 24 Mark-Christensen A, Erichsen R, Brandsborg S. et al. Pouch failures following ileal pouch-anal anastomosis for ulcerative colitis. Colorectal Dis 2018; 20 (01) 44-52
    CrossrefPubMedGoogle Scholar
  • 25 Mark-Christensen A, Brandsborg S, Laurberg S. Primary fecal diversion and bowel dysfunction in restorative proctocolectomy for ulcerative colitis: a nationwide cross-sectional study. Int J Colorectal Dis 2018; 33 (02) 223-229
    CrossrefPubMedGoogle Scholar
  • 26 Mayberry J. The history of 5-ASA compounds and their use in ulcerative colitis–trailblazing discoveries in gastroenterology. J Gastrointestin Liver Dis 2013; 22 (04) 375-377
    PubMedGoogle Scholar
  • 27 Blomberg B, Järnerot G. Clinical evaluation and management of acute severe colitis. Inflamm Bowel Dis 2000; 6 (03) 214-227
    CrossrefPubMedGoogle Scholar
  • 28 Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995; 1 (01) 48-63
    CrossrefPubMedGoogle Scholar
  • 29 Sandborn WJ, Van Assche G, Reinisch W, Colombel JF, D'Haens G, Wolf DC. et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2012; 142 (02) 257-265.e3
    CrossrefPubMedGoogle Scholar
  • 30 Peyrin-Biroulet L, Laclotte C, Roblin X, Bigard MA. Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. World J Gastroenterol 2007; 13 (16) 2328-2332
    CrossrefPubMedGoogle Scholar
  • 31 Cunningham G, Samaan MA, Irving PM. Golimumab in the treatment of ulcerative colitis. Therap Adv Gastroenterol 2019; 12: 1756284818821266
    CrossrefPubMedGoogle Scholar
  • 32 Flamant M, Paul S, Roblin X. Golimumab for the treatment of ulcerative colitis. Expert Opin Biol Ther 2017; 17 (07) 879-886
    CrossrefPubMedGoogle Scholar
  • 33 Feagan BG, Rutgeerts P, Sands BE. et al; GEMINI 1 Study Group. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013; 369 (08) 699-710
    CrossrefPubMedGoogle Scholar
  • 34 Stallmach A, Schmidt C, Teich N. Vedolizumab for the treatment of ulcerative colitis. Expert Rev Gastroenterol Hepatol 2016; 10 (02) 165-175
    CrossrefPubMedGoogle Scholar
  • 35 Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31 (03) 329-333
    CrossrefPubMedGoogle Scholar
  • 36 Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107 (01) 3-11
    CrossrefPubMedGoogle Scholar
  • 37 Reich KM, Chang HJ, Rezaie A. et al. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study. Aliment Pharmacol Ther 2014; 40 (06) 629-638
    CrossrefPubMedGoogle Scholar
  • 38 Solberg IC, Lygren I, Jahnsen J. et al; IBSEN Study Group. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009; 44 (04) 431-440
    CrossrefPubMedGoogle Scholar
  • 39 Rungoe C, Langholz E, Andersson M. et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 2014; 63 (10) 1607-1616
    CrossrefPubMedGoogle Scholar
  • 40 Lucaciu LA, Seicean R, Seicean A. Small molecule drugs in the treatment of inflammatory bowel diseases: which one, when and why? A systematic review. Eur J Gastroenterol Hepatol 2020; 32 (06) 669-677
    CrossrefPubMedGoogle Scholar
  • 41 Lovegrove RE, Tilney HS, Heriot AG. et al. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum 2006; 49 (09) 1293-1306
    CrossrefPubMedGoogle Scholar
  • 42 Zmora O, Khaikin M, Pishori T. et al. Should ileoanal pouch surgery be staged for patients with mucosal ulcerative colitis on immunosuppressives?. Int J Colorectal Dis 2007; 22 (03) 289-292
    CrossrefPubMedGoogle Scholar
  • 43 Lim M, Sagar P, Abdulgader A, Thekkinkattil D, Burke D. The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis. Dis Colon Rectum 2007; 50 (07) 943-951
    CrossrefPubMedGoogle Scholar
  • 44 Ritter KA, Burke JP, Stocchi L. et al. Postoperative steroid taper is associated with pelvic sepsis after ileal pouch-anal anastomosis. Inflamm Bowel Dis 2019; 25 (08) 1383-1389
    CrossrefPubMedGoogle Scholar
  • 45 Markel TA, Lou DC, Pfefferkorn M. et al. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery 2008; 144 (04) 540-545 , discussion 545–547
    CrossrefPubMedGoogle Scholar
  • 46 Mahadevan U, Loftus Jr EV, Tremaine WJ. et al. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis 2002; 8 (05) 311-316
    CrossrefPubMedGoogle Scholar
  • 47 Schluender SJ, Ippoliti A, Dubinsky M. et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?. Dis Colon Rectum 2007; 50 (11) 1747-1753
    CrossrefPubMedGoogle Scholar
  • 48 Colombel JF, Loftus Jr EV, Tremaine WJ. et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99 (05) 878-883
    CrossrefPubMedGoogle Scholar
  • 49 Regadas FS, Pinto RA, Murad-Regadas SM. et al. Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal. Colorectal Dis 2011; 13 (05) 555-560
    CrossrefPubMedGoogle Scholar
  • 50 Selvaggi F, Pellino G, Canonico S, Sciaudone G. Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis. Inflamm Bowel Dis 2015; 21 (01) 79-92
    CrossrefPubMedGoogle Scholar
  • 51 Iesalnieks I, Kilger A, Glass H. et al. Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome. Int J Colorectal Dis 2008; 23 (12) 1167-1174
    CrossrefPubMedGoogle Scholar
  • 52 Iesalnieks I, Kilger A, Glass H, Obermeier F, Agha A, Schlitt HJ. Perforating Crohn's ileitis: delay of surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis 2010; 16 (12) 2125-2130
    CrossrefPubMedGoogle Scholar
  • 53 Kim JY, Zaghiyan K, Lightner A, Fleshner P. Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study. BMC Surg 2020; 20 (01) 46
    CrossrefPubMedGoogle Scholar
  • 54 Ferrante M, de Buck van Overstraeten A, Schils N. et al. Perioperative use of vedolizumab is not associated with postoperative infectious complications in patients with ulcerative colitis undergoing colectomy. J Crohn's Colitis 2017; 11 (11) 1353-1361
    CrossrefPubMedGoogle Scholar
  • 55 Lightner AL, McKenna NP, Moncrief S, Pemberton JH, Raffals LE, Mathis KL. Surgical outcomes in vedolizumab-treated patients with ulcerative colitis. Inflamm Bowel Dis 2017; 23 (12) 2197-2201
    CrossrefPubMedGoogle Scholar
  • 56 Bertucci Zoccali M, Hyman NH, Skowron KB. et al. Exposure to anti-tumor necrosis factor medications increases the incidence of pouchitis after restorative proctocolectomy in patients with ulcerative colitis. Dis Colon Rectum 2019; 62 (11) 1344-1351
    CrossrefPubMedGoogle Scholar
  • 57 Lee GC, Deery SE, Kunitake H. et al. Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis. Int J Colorectal Dis 2019; 34 (03) 491-499
    CrossrefPubMedGoogle Scholar
  • 58 Sahami S, Buskens CJ, Fadok TY. et al. Defunctioning ileostomy is not associated with reduced leakage in proctocolectomy and ileal pouch anastomosis surgeries for IBD. J Crohn's Colitis 2016; 10 (07) 779-785
    CrossrefPubMedGoogle Scholar
  • 59 Kochar B, Barnes EL, Peery AF. et al. Delayed ileal pouch anal anastomosis has a lower 30-day adverse event rate: analysis from the national surgical quality improvement program. Inflamm Bowel Dis 2018; 24 (08) 1833-1839
    CrossrefPubMedGoogle Scholar
  • 60 Zittan E, Wong-Chong N, Ma GW, McLeod RS, Silverberg MS, Cohen Z. Modified two-stage ileal pouch-anal anastomosis results in lower rate of anastomotic leak compared with traditional two-stage surgery for ulcerative colitis. J Crohn's Colitis 2016; 10 (07) 766-772
    CrossrefPubMedGoogle Scholar
  • 61 Swenson BR, Hollenbeak CS, Poritz LS, Koltun WA. Modified two-stage ileal pouch-anal anastomosis: equivalent outcomes with less resource utilization. Dis Colon Rectum 2005; 48 (02) 256-261
    CrossrefPubMedGoogle Scholar
  • 62 Mennigen R, Senninger N, Bruwer M, Rijcken E. Impact of defunctioning loop ileostomy on outcome after restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis 2011; 26 (05) 627-633
    CrossrefPubMedGoogle Scholar
  • 63 Heuschen UA, Hinz U, Allemeyer EH, Lucas M, Heuschen G, Herfarth C. One- or two-stage procedure for restorative proctocolectomy: rationale for a surgical strategy in ulcerative colitis. Ann Surg 2001; 234 (06) 788-794
    CrossrefPubMedGoogle Scholar
  • 64 Lavryk OA, Hull TL, Duraes LC. et al. Outcomes of ileal pouch-anal anastomosis without primary diverting loop ileostomy if postoperative sepsis develops. Tech Coloproctol 2018; 22 (01) 37-44
    CrossrefPubMedGoogle Scholar
  • 65 Gunnarsson U, Karlbom U, Docker M, Raab Y, Påhlman L. Proctocolectomy and pelvic pouch—is a diverting stoma dangerous for the patient?. Colorectal Dis 2004; 6 (01) 23-27
    CrossrefPubMedGoogle Scholar
  • 66 Luo WY, Singh S, Cuomo R, Eisenstein S. Modified two-stage restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: a systematic review and meta-analysis of observational research. Int J Colorectal Dis 2020; 35 (10) 1817-1830
    CrossrefPubMedGoogle Scholar
  • 67 Beyer-Berjot L, Baumstarck K, Loubière S. et al; GETAID Chirurgie group. Is diverting loop ileostomy necessary for completion proctectomy with ileal pouch-anal anastomosis? A multicenter randomized trial of the GETAID Chirurgie group (IDEAL trial): rationale and design (NCT03872271). BMC Surg 2019; 19 (01) 192
    CrossrefPubMedGoogle Scholar
  • 68 Guagnozzi D, Lucendo AJ. Colorectal cancer surveillance in patients with inflammatory bowel disease: what is new?. World J Gastrointest Endosc 2012; 4 (04) 108-116
    CrossrefPubMedGoogle Scholar
  • 69 Gao P, Huang XZ, Song YX. et al. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study. BMC Cancer 2018; 18 (01) 234
    CrossrefPubMedGoogle Scholar
  • 70 Wu XR, Kiran RP, Remzi FH, Katz S, Mukewar S, Shen B. Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer. J Crohn's Colitis 2013; 7 (10) e419-e426
    CrossrefPubMedGoogle Scholar
  • 71 Myrelid P, Lovegrove R, Lovegrove R. Low rectal cancer in a patient with ulcerative colitis: late reconstruction with continent Kock ileostomy. In: George B, Guy R, Jones O, Vogel J. eds. Colorectal Surgery: Clinical Care and Management. Oxford: Wiley Blackwell; 2016: 135-140
    CrossrefGoogle Scholar
  • 72 Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Surgery 2005; 138 (04) 631-637 , discussion 637–639
    CrossrefPubMedGoogle Scholar
  • 73 Obusez EC, Lian L, Shao Z. et al. Impact of ileal pouch-anal anastomosis on the surgical outcome of orthotopic liver transplantation for primary sclerosing cholangitis. J Crohn's Colitis 2013; 7 (03) 230-238
    CrossrefPubMedGoogle Scholar
  • 74 Nordenvall C, Olén O, Johan Nilsson P. et al. Restorative surgery in patients with primary sclerosing cholangitis and ulcerative colitis following a colectomy. Inflamm Bowel Dis 2018; 24 (03) 624-632
    CrossrefPubMedGoogle Scholar
  • 75 Mathis KL, Benavente-Chenhalls LA, Dozois EJ, Wolff BG, Larson DW. Short- and long-term surgical outcomes in patients undergoing proctocolectomy with ileal pouch-anal anastomosis in the setting of primary sclerosing cholangitis. Dis Colon Rectum 2011; 54 (07) 787-792
    CrossrefPubMedGoogle Scholar
  • 76 Block M, Jørgensen KK, Öresland T. et al. Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis—what next?. J Crohn's Colitis 2014; 8 (05) 421-430
    CrossrefPubMedGoogle Scholar
  • 77 Fazio VW, Kiran RP, Remzi FH. et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257 (04) 679-685
    CrossrefPubMedGoogle Scholar
  • 78 Rottoli M, Di Simone MP, Vallicelli C. et al. Endoluminal vacuum-assisted therapy as treatment for anastomotic leak after ileal pouch-anal anastomosis: a pilot study. Tech Coloproctol 2018; 22 (03) 223-229
    CrossrefPubMedGoogle Scholar
  • 79 Gardenbroek TJ, Musters GD, Buskens CJ. et al. Early reconstruction of the leaking ileal pouch-anal anastomosis: a novel solution to an old problem. Colorectal Dis 2015; 17 (05) 426-432
    CrossrefPubMedGoogle Scholar
  • 80 Sossenheimer PH, Glick LR, Dachman AH. et al. Abnormal pouchogram predicts pouch failure even in asymptomatic patients. Dis Colon Rectum 2019; 62 (04) 463-469
    CrossrefPubMedGoogle Scholar
  • 81 Pellino G, Selvaggi F. Outcomes of salvage surgery for ileal pouch complications and dysfunctions. the experience of a referral centre and review of literature. J Crohn's Colitis 2015; 9 (07) 548-557
    CrossrefPubMedGoogle Scholar
  • 82 Remzi FH, Aytac E, Ashburn J. et al. Transabdominal redo ileal pouch surgery for failed restorative proctocolectomy: lessons learned over 500 patients. Ann Surg 2015; 262 (04) 675-682
    CrossrefPubMedGoogle Scholar
  • 83 Remzi FH, Fazio VW, Kirat HT, Wu JS, Lavery IC, Kiran RP. Repeat pouch surgery by the abdominal approach safely salvages failed ileal pelvic pouch. Dis Colon Rectum 2009; 52 (02) 198-204
    CrossrefPubMedGoogle Scholar